Literature DB >> 21896761

Reactibodies generated by kinetic selection couple chemical reactivity with favorable protein dynamics.

Ivan Smirnov1, Eugénie Carletti, Inna Kurkova, Florian Nachon, Yvain Nicolet, Vladimir A Mitkevich, Hélène Débat, Bérangère Avalle, Alexey A Belogurov, Nikita Kuznetsov, Andrey Reshetnyak, Patrick Masson, Alexander G Tonevitsky, Natalia Ponomarenko, Alexander A Makarov, Alain Friboulet, Alfonso Tramontano, Alexander Gabibov.   

Abstract

Igs offer a versatile template for combinatorial and rational design approaches to the de novo creation of catalytically active proteins. We have used a covalent capture selection strategy to identify biocatalysts from within a human semisynthetic antibody variable fragment library that uses a nucleophilic mechanism. Specific phosphonylation at a single tyrosine within the variable light-chain framework was confirmed in a recombinant IgG construct. High-resolution crystallographic structures of unmodified and phosphonylated Fabs display a 15-Å-deep two-chamber cavity at the interface of variable light (V(L)) and variable heavy (V(H)) fragments having a nucleophilic tyrosine at the base of the site. The depth and structure of the pocket are atypical of antibodies in general but can be compared qualitatively with the catalytic site of cholinesterases. A structurally disordered heavy chain complementary determining region 3 loop, constituting a wall of the cleft, is stabilized after covalent modification by hydrogen bonding to the phosphonate tropinol moiety. These features and presteady state kinetics analysis indicate that an induced fit mechanism operates in this reaction. Mutations of residues located in this stabilized loop do not interfere with direct contacts to the organophosphate ligand but can interrogate second shell interactions, because the H3 loop has a conformation adjusted for binding. Kinetic and thermodynamic parameters along with computational docking support the active site model, including plasticity and simple catalytic components. Although relatively uncomplicated, this catalytic machinery displays both stereo- and chemical selectivity. The organophosphate pesticide paraoxon is hydrolyzed by covalent catalysis with rate-limiting dephosphorylation. This reactibody is, therefore, a kinetically selected protein template that has enzyme-like catalytic attributes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21896761      PMCID: PMC3179052          DOI: 10.1073/pnas.1108460108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition.

Authors:  I Jelesarov; H R Bosshard
Journal:  J Mol Recognit       Date:  1999 Jan-Feb       Impact factor: 2.137

2.  Conformational changes affect binding and catalysis by ester-hydrolysing antibodies.

Authors:  A B Lindner; Z Eshhar; D S Tawfik
Journal:  J Mol Biol       Date:  1999-01-08       Impact factor: 5.469

3.  Immune versus natural selection: antibody aldolases with enzymic rates but broader scope.

Authors:  C F Barbas; A Heine; G Zhong; T Hoffmann; S Gramatikova; R Björnestedt; B List; J Anderson; E A Stura; I A Wilson; R A Lerner
Journal:  Science       Date:  1997-12-19       Impact factor: 47.728

4.  Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase.

Authors:  P Kuzmic
Journal:  Anal Biochem       Date:  1996-06-01       Impact factor: 3.365

5.  Structural insights into the evolution of an antibody combining site.

Authors:  G J Wedemayer; P A Patten; L H Wang; P G Schultz; R C Stevens
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

6.  The immunological evolution of catalysis.

Authors:  P A Patten; N S Gray; P L Yang; C B Marks; G J Wedemayer; J J Boniface; R C Stevens; P G Schultz
Journal:  Science       Date:  1996-02-23       Impact factor: 47.728

7.  Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes.

Authors:  J Wagner; R A Lerner; C F Barbas
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

8.  Conformational isomerism and the diversity of antibodies.

Authors:  J Foote; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

9.  Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase.

Authors:  D S Jackson; S A Fraser; L M Ni; C M Kam; U Winkler; D A Johnson; C J Froelich; D Hudig; J C Powers
Journal:  J Med Chem       Date:  1998-06-18       Impact factor: 7.446

10.  Isolation of high affinity human antibodies directly from large synthetic repertoires.

Authors:  A D Griffiths; S C Williams; O Hartley; I M Tomlinson; P Waterhouse; W L Crosby; R E Kontermann; P T Jones; N M Low; T J Allison
Journal:  EMBO J       Date:  1994-07-15       Impact factor: 11.598

View more
  10 in total

1.  Constant domain-regulated antibody catalysis.

Authors:  Gopal Sapparapu; Stephanie Planque; Yukie Mitsuda; Gary McLean; Yasuhiro Nishiyama; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

2.  Chemical polysialylation of human recombinant butyrylcholinesterase delivers a long-acting bioscavenger for nerve agents in vivo.

Authors:  Denis G Ilyushin; Ivan V Smirnov; Alexey A Belogurov; Igor A Dyachenko; Tatiana Iu Zharmukhamedova; Tatjana I Novozhilova; Eugene A Bychikhin; Marina V Serebryakova; Oleg N Kharybin; Arkadii N Murashev; Konstantin A Anikienko; Eugene N Nikolaev; Natalia A Ponomarenko; Dmitry D Genkin; G Michael Blackburn; Patrick Masson; Alexander G Gabibov
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

3.  Evolution of catalytic centers of antibodies by virtual screening of broad repertoire of mutants using supercomputer.

Authors:  A V Golovin; I V Smirnov; A V Stepanova; A O Zalevskiy; A S Zlobin; N A Ponomarenko; A A Belogurov; V D Knorre; E N Hurs; S D Chatziefthimiou; M Wilmanns; G M Blackburn; R M Khomutov; A G Gabibov
Journal:  Dokl Biochem Biophys       Date:  2017-09-02       Impact factor: 0.788

4.  Robotic QM/MM-driven maturation of antibody combining sites.

Authors:  Ivan V Smirnov; Andrey V Golovin; Spyros D Chatziefthimiou; Anastasiya V Stepanova; Yingjie Peng; Olga I Zolotareva; Alexey A Belogurov; Inna N Kurkova; Natalie A Ponomarenko; Matthias Wilmanns; G Michael Blackburn; Alexander G Gabibov; Richard A Lerner
Journal:  Sci Adv       Date:  2016-10-19       Impact factor: 14.136

5.  Mouse Model for Assessing the Subchronic Toxicity of Organophosphate Pesticides.

Authors:  V A Palikov; S S Terekhov; Yu A Palikova; O N Khokhlova; V A Kazakov; I A Dyachenko; S V Panteleev; Yu A Mokrushina; V D Knorre; O G Shamborant; I V Smirnov; A G Gabibov
Journal:  Acta Naturae       Date:  2018 Oct-Dec       Impact factor: 1.845

Review 6.  Catalytic Antibodies: Design, Expression, and Their Applications in Medicine.

Authors:  Daqun Zhao; Jie Chen; Xiaoyue Hu; Shujun Zhang
Journal:  Appl Biochem Biotechnol       Date:  2022-10-12       Impact factor: 3.094

7.  Biochemical features of a catalytic antibody light chain, 22F6, prepared from human lymphocytes.

Authors:  Emi Hifumi; Naoko Fujimoto; Mitsue Arakawa; Eri Saito; Shingo Matsumoto; Nobuyuki Kobayashi; Taizo Uda
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

8.  Role of κ→λ light-chain constant-domain switch in the structure and functionality of A17 reactibody.

Authors:  Natalia Ponomarenko; Spyros D Chatziefthimiou; Inna Kurkova; Yuliana Mokrushina; Yuliana Mokrushina; Anastasiya Stepanova; Ivan Smirnov; Marat Avakyan; Tatyana Bobik; Azad Mamedov; Vladimir Mitkevich; Alexey Belogurov; Olga S Fedorova; Michael Dubina; Andrey Golovin; Victor Lamzin; Alain Friboulet; Alexander A Makarov; Matthias Wilmanns; Alexander Gabibov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-02-15

9.  Multiple sclerosis autoantigen myelin basic protein escapes control by ubiquitination during proteasomal degradation.

Authors:  Alexey Belogurov; Anna Kudriaeva; Ekaterina Kuzina; Ivan Smirnov; Tatyana Bobik; Natalia Ponomarenko; Yelena Kravtsova-Ivantsiv; Aaron Ciechanover; Alexander Gabibov
Journal:  J Biol Chem       Date:  2014-04-16       Impact factor: 5.157

10.  Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States.

Authors:  Evgeny A Ermakov; Georgy A Nevinsky; Valentina N Buneva
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.